HomeGLENMARK • NSE
add
Glenmark Pharmaceuticals Ltd
Previous close
₹1,898.40
Day range
₹1,842.90 - ₹1,907.90
Year range
₹1,275.50 - ₹2,284.80
Market cap
520.94B INR
Avg Volume
546.36K
P/E ratio
69.13
Dividend yield
0.20%
Primary exchange
NSE
Financials
Income Statement
Revenue
Net income
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 32.64B | 0.62% |
Operating expense | 17.98B | 8.09% |
Net income | 468.71M | -86.23% |
Net profit margin | 1.44 | -86.27% |
Earnings per share | 7.29 | -39.58% |
EBITDA | 5.72B | -8.92% |
Effective tax rate | 50.85% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.05B | 2.76% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 88.49B | — |
Shares outstanding | 282.36M | — |
Price to book | 6.23 | — |
Return on assets | — | — |
Return on capital | 9.95% | — |
Cash Flow
Net change in cash
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 468.71M | -86.23% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Wikipedia
Founded
Nov 18, 1977
Website
Employees
15,800
